Menu Back to Committee

Programme Steering Committee, Advisors and Topic Leaders

Introducing the DIA Europe 2018 Programme Steering Committee

REGULATORY SCIENCE CO-CHAIRS:

Pani Luca Luca Pani
Professor, Department of Psychiatry and Behavioral Sciences, University Of Miami School Of Medicine; Executive Director of Global Medical Innovation NeuroCog, USA


Michelle Rohrer
Michelle Rohrer
Global Head of PD Regulatory and Policy
F. Hoffmann-La Roche and Genentech, Switzerland


VALUE & ACCESS CO-CHAIRS:

Jens Grueger Jens Grueger
Head of Global Pricing & Market Access
F. Hoffmann-La Roche, Switzerland


Ad Schuurman
A.R. (Ad) Schuurman
Head of International Department
National Health Care Institute (ZIN), Netherlands


TRANSLATIONAL MEDICINE & SCIENCE CHAIR:

Salah Dine Chibout
Salah-Dine Chibout
Global Head of Discovery & Investigative Safety (DIS)
Novartis Institutes, Switzerland

Program Committee

  • Salah-Dine  Chibout
    Salah-Dine Chibout Global Head Discovery & Investigative Safety/Preclinical Safety Therapeutic Area
    Novartis Pharma AG, Switzerland
  • Jens  Grueger, PhD
    Jens Grueger, PhD Head Global Pricing & Market Access, Pharma Division
    F. Hoffmann-La Roche, Switzerland
  • Luca  Pani, MD
    Luca Pani, MD Former, AIFA; Professor, Department of Psychiatry and Behavioral Sciences
    University of Miami, United States
  • Michelle  Rohrer, PhD
    Michelle Rohrer, PhD Vice President, Global Head Regulatory Regions and Policy
    Genentech, A Member of the Roche Group , United States
  • Vivianne  Arencibia
    Vivianne Arencibia Global Vice President, Head External Relations
    Novartis Pharmaceuticals Corporation, United States
  • Sabine  Atzor, RPh
    Sabine Atzor, RPh Head of EU Regulatory Policies
    F. Hoffmann-La Roche, Switzerland
  • Ursula  Busse, PhD, MBA
    Ursula Busse, PhD, MBA Head of Quality Intelligence, External Engagement
    Novartis, Switzerland
  • João  Duarte, MPharm
    João Duarte, MPharm Associate Director, Europe Regulatory Policy & Intelligence
    Takeda, United Kingdom
  • Sabine  Haubenreisser, PhD, MSc
    Sabine Haubenreisser, PhD, MSc Principal Scientific Administrator, International Affairs
    European Medicines Agency (EMA), United Kingdom
  • Cordula  Landgraf, RPh
    Cordula Landgraf, RPh Head of Networking
    Swissmedic, Switzerland
  • Francesco  Pignatti, MD
    Francesco Pignatti, MD Head of Oncology, Haematology, Diagnostics
    European Medicines Agency (EMA), United Kingdom
  • Bettina  Ryll
    Bettina Ryll Founder
    Melanoma Patient Network Europe, Sweden
  • Claudine  Sapède, PharmD, MSc
    Claudine Sapède, PharmD, MSc Global HTA and Payment Policy Lead
    F. Hoffmann-La Roche, Switzerland
  • Ad  Schuurman, MBA, MSc
    Ad Schuurman, MBA, MSc Head of the Business Contact Centre & International Affairs
    National Health Care Institute (ZIN), Netherlands
  • Indranil  Bagchi, PhD, MS
    Indranil Bagchi, PhD, MS SVP and Head, Global Value and Access
    Novartis Oncology, United States
  • Isabelle M de Zegher, MD, MSc
    Isabelle M de Zegher, MD, MSc Vice President
    PAREXEL Informatics, Belgium
  • Petra  Doerr, PharmD, PhD, RPh
    Petra Doerr, PharmD, PhD, RPh Deputy Executive Director
    Swissmedic, Switzerland
  • Vicki  Edwards, RPh
    Vicki Edwards, RPh Vice President, Pharmacovigilance Excellence and QPPV
    AbbVie, Inc., United Kingdom
  • Georgy  Genov, MD
    Georgy Genov, MD Head of Signal and Incident Management
    European Medicines Agency, European Union, United Kingdom
  • Anthony  Humphreys, MPharm
    Anthony Humphreys, MPharm Head of Committee Secretariat Department
    European Medicines Agency, European Union , United Kingdom
  • Merete  Joergensen, MBA, MSc
    Merete Joergensen, MBA, MSc Senior Trial Disclosure Director, Global Clinical Registry
    Novo Nordisk A/S, Denmark
  • Jordi  Llinares Garcia, MS
    Jordi Llinares Garcia, MS Head of Scientific and Regulatory Management
    European Medicines Agency (EMA), United Kingdom
  • Manfred  Maeder, PhD
    Manfred Maeder, PhD Head of Device Development & Commercialization
    Novartis, Switzerland
  • Thomas  Metcalfe, MBA
    Thomas Metcalfe, MBA Strategic Innovation Leader, Pharma Development
    1959, Switzerland
  • Sharon N. Olmstead
    Sharon N. Olmstead Global Head, Development and Regulatory Policy
    Novartis Pharmaceuticals Corporation, United States
  • Not Confirmed
    Representative Invited Merck KGaA, Germany
  • Thomas  Senderovitz, DrMed, MD
    Thomas Senderovitz, DrMed, MD Director General
    Danish Medicines Agency, Denmark
  • Not Confirmed
    Representative Invited European Medicines Agency, European Union, United Kingdom
Load More